LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Drug-Resistant breast cancer: phase 3 trial launches
Disease control Recruiting nowThis phase 3 trial is testing whether a new drug called HRS-8080, combined with dalpiciclib, works better than the standard treatment (fulvestrant plus dalpiciclib) for people with advanced breast cancer that has become resistant to hormone therapy. About 912 women aged 18-75 wit…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for advanced breast cancer: YL202 takes on standard treatments in major trial
Disease control Recruiting nowThis phase 3 study tests whether the experimental drug YL202 works better than standard treatments (like eribulin or capecitabine) for people with a common type of advanced breast cancer (HR+/HER2-) that has not responded to at least one chemotherapy. About 376 participants will …
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for advanced breast cancer: drug combo targets resistant tumors
Disease control Recruiting nowThis study tests a new oral drug called SPH4336 combined with hormone therapy (letrozole or fulvestrant) in people with a common type of advanced breast cancer (HR-positive, HER2-negative) that has worsened after prior treatment. About 254 participants will receive either the dru…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for advanced breast cancer: experimental combo enters final testing
Disease control Recruiting nowThis Phase 3 trial tests whether an experimental drug called SIM0270 combined with everolimus works better than standard treatments for people with ER+/HER2- advanced or metastatic breast cancer that has worsened after CDK4/6 inhibitor therapy. About 460 participants will be rand…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Simple gloves and socks may shield breast cancer patients from chemo nerve pain
Symptom relief Recruiting nowThis study tests whether wearing compression or ice gloves and socks can reduce nerve damage caused by the chemotherapy drug UTD1 in women with advanced breast cancer. 324 participants will be randomly assigned to wear nothing, compression gloves/socks, or ice gloves/socks during…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC